bioRxiv / medRxiv
open access
CC BY-NC-ND 4.0
New tests for trials of very few patients using longitudinal data - a case-study in Autosomal Recessive Cerebellar Ataxias
We propose two new tests to detect drug effects (DE) in trials of one to very few patients followed during two periods (before and after initiation of a treatment). Both methods use longitudinal natural history data to inform the estimation of each patients DE. The first method uses a non-linear mix
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Biomarker for Friedreich's Ataxia (BioFridA)#901247
- Predicting disease progression in progressive cerebellar ataxias: integrating clinical, imaging, fluid, genetic, and digital biomarkers.#630842
- Drug Recalls in Spain: A 14-year Retrospective Regulatory Analysis in Spain#414842
- International Ataxia Rating Scale in Younger Patients#1171224
- Automatic longitudinal assessment of brain metastases improves detection of disease progression.#15170
Record · ID 1149591
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive